CD1 Non-invasive diagnostic tool for detecting cardiovascular disease in diabetes (ICDM) | Thursday, 7 November 10:20~11:50 / Convention hall A Chair: Young-Kil Choi |
CD3 Diabetes and cancer (ICDM) | Thursday, 7 November 16:00~17:30 / Convention hall A Chair: Lee-Ming Chuang |
CD5 Updates of anti-diabetic agents (ICDM) | Friday, 8 November 09:00~10:30 / Convention hall A Chair: Sei Hyun Baik |
Eun-Jung Rhee Sungkyunkwan University, Korea |
CD5-1 Ongoing clinical trials of new anti-diabetic agents | ||
Byung-Joon Kim Gachon University, Korea |
CD5-2 Updates of GLP-1 and DPP4 inhibitors | ||
Byung-Wan Lee Yonsei University, Korea |
CD5-3 Developing anti-diabetic agents targeting the liver |
CD7 Measurement of insulin resistance and secretion in diabetes clinic (ICDM) | Friday, 8 November 15:00~16:30 / Convention hall A Chair: Yeon-Ah Sung |
CD8 Recent update on CVD risk management in type 2 diabetes (ICDM) | Saturday, 9 November 09:00~10:30 / Convention hall A Chair: In Joo Kim |
CD10 Large clinical studies in Asia (AASD) | Saturday, 9 November 14:30~16:00 / Convention hall A Chair: Wayne H-H Sheu |
Juliana Chan The Chinese University of Hong Kong, Hong Kong |
CD10-1 What can we learn from large clinical databases? | ||
Soo Lim Seoul National University, Korea |
CD10-2 Association of vitamin D deficiency with cardiometabolic risk in high risk Asian subjects | ||
Takayoshi Sasako University of Tokyo, Japan |
CD10-3 J-DOIT3 |